Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
NPPNY:OTCMKTS
Nippon Shinyak Unsponsored ADR Representing Ord Shs
$8.15
0.00%
(0.00) 1D
Apr 15, 2:00:48 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NPPNY...
Mkt. cap
345.01B
Avg. vol.
896.00
Volume
5.00
52-wk high
$15.21
52-wk low
$5.03
Beta
-0.05
Shares outstanding
281.00M
No. of employees
2K
News stories
From sources across the web
Profile
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
About Nippon Shinyak Unsponsored ADR Representing Ord Shs
CEO-
Employees2.24K
FoundedOct 1, 1919
Headquarters-
SectorPharmaceutical industry
Websitenippon-shinyaku.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
38.91B
39.55B
40.10B
47.49B
Cost of goods sold
12.31B
12.66B
12.68B
16.68B
Cost of revenue
12.31B
12.66B
12.68B
16.68B
Research and development expenses
10.79B
6.19B
8.45B
8.40B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.43B
10.00B
10.36B
11.35B
Operating expense
22.43B
16.81B
17.92B
18.06B
Total operating expenses
34.74B
29.46B
30.60B
34.73B
Operating income
4.17B
10.08B
9.50B
12.75B
Other non operating income
337.00M
-2.00M
1.00M
-2.00M
EBT including unusual items
2.70B
10.50B
9.53B
13.20B
EBT excluding unusual items
3.74B
10.50B
9.53B
13.20B
Income tax expense
-1.31B
2.25B
2.02B
3.11B
Effective tax rate
-48.44%
21.40%
21.19%
23.57%
Other operating expenses
1.19B
625.00M
-888.00M
-1.68B
Net income
4.01B
8.26B
7.50B
10.08B
Net profit margin
10.29%
20.87%
18.72%
21.23%
Earnings per share
-
-
-
-
Interest and investment income
54.00M
468.00M
82.00M
464.00M
Interest expense
-12.00M
-46.00M
-55.00M
-19.00M
Net interest expenses
42.00M
422.00M
27.00M
445.00M
Depreciation and amortization charges
1.02B
-
-
-
EBITDA
5.67B
11.67B
11.14B
14.41B
Gain or loss from assets sale
856.00M
-
19.00M
56.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer